genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2016
Chronic pain
Industry News
Principia Invests €4M in Human Tissue Drug Discovery Firm AnaBios
Drug Discovery
New Compound May Treat Pain without Opioid- or Marijuana-Use Side Effects
Drug Discovery
Teva Partners with Regeneron to Develop Pain Candidate Fasinumab
Drug Discovery
Asahi Kasei Pharma to Co-Develop Array BioPharma’s Pain Candidates
Drug Discovery
MannKind Licenses Technology to Seattle Startup
Drug Discovery
Purdue Pharma Acquires TrkA Inhibitor Program for Up to $213M+
News
Legalizing Medicinal Marijuana
Infectious Diseases
Vestiq Pays $44M to Market BioAlliance’s Oravig in the U.S.
News
ALS Institute, Neurotune to Evaluate Amyotrophic Lateral Sclerosis Therapeutic Candidate
Drug Discovery
Salix Nabs Ex-Japanese License to Progenics’ OIC Therapy Relistor for $60M Up Front
1
2
3
4
5
Page 3 of 5
Scroll Up